XELJANZ 1 mg/mL
tofacitinib · SOLUTION · U.S. Pharmaceuticals
No Recall History
Plain English
XELJANZ is a solution containing tofacitinib at 1 mg/mL, taken oral. Manufactured by U.S. Pharmaceuticals.
Key Facts
- Brand Name
- XELJANZ
- Generic Name
- tofacitinib
- NDC Code (Product)
63539-029- Manufacturer
- U.S. Pharmaceuticals
- Strength
- 1 mg/mL
- Dosage Form
- SOLUTION
- Route
- ORAL
- Marketing Status
- Application #
- NDA213082
- Marketing Start
- 02/08/2021
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
drug ineffective43,682 reports
pain25,882 reports
arthralgia19,814 reports
condition aggravated19,599 reports
rheumatoid arthritis18,924 reports
fatigue16,715 reports
off label use14,971 reports
joint swelling14,574 reports
headache13,533 reports
rash12,041 reports
Frequently Asked Questions
What is XELJANZ used for?
XELJANZ contains tofacitinib. It is a solution taken oral. Consult your doctor for specific uses.
Is XELJANZ a controlled substance?
XELJANZ is not classified as a controlled substance by the DEA.
What is the generic name for XELJANZ?
The generic name for XELJANZ is tofacitinib. There are 9 other brand versions of tofacitinib.
What is the NDC code for XELJANZ 1 mg/mL?
The NDC (National Drug Code) for XELJANZ 1 mg/mL is 63539-029, listed by U.S. Pharmaceuticals.